Hep C Discussion Forum
Login
Menu
Clinical trial news feed
Mary Jane said
Aug 31, 2012
ClinicalTrials.gov: hepatitis c | Exclude Unknown | received from 05/01/2012 to 06/30/2012 | updated in the last 30 days
Wednesday, August 29, 2012, 11:53:03 AM
Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C
Tuesday, June 26, 2012, 12:00:00 PM
Condition
: Hepatitis C Virus
Interventions
: Drug: Daclatasvir; Drug: Daclatasvir; Drug: BMS-986094; Drug: BMS-986094; Drug: BMS-986094; Drug: Ribavirin; Drug: Placebo for BMS-986094
Sponsors
: Bristol-Myers Squibb; Bristol-Myers Squibb
Suspended
- verified August 2012
ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment
Friday, June 22, 2012, 12:00:00 PM
Condition
: Hepatitis C, Chronic
Interventions
: Drug: RO5466731; Drug: RO5190591; Drug: ritonavir; Drug: ribavirin [Copegus]; Drug: RO5024048
Sponsors
: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting
- verified August 2012
Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health Outcomes
Monday, June 11, 2012, 12:00:00 PM
Condition
: Hepatitis C
Intervention
: Drug: Interferon-alpha
Sponsors
: University of Arizona; University of Arizona; Emory University; National Center for Complementary and Alternative Medicine (NCCAM)
Active, not recruiting
- verified August 2012
Open-Label Study of GS-7977+ Ribavirin for 12 Weeks in Subjects With Chronic HCV Infection
Thursday, June 07, 2012, 12:00:00 PM
Condition
: Chronic Hepatitis C
Intervention
: Drug: GS-7977 in combination with ribavirin
Sponsors
: Gilead Sciences; Gilead Sciences
Recruiting
- verified August 2012
A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon -2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous Abbott Combination Study
Wednesday, May 30, 2012, 12:00:00 PM
Condition
: Hepatitis C (HCV), Chronic Hepatitis C
Interventions
: Drug: ABT-450/r; Drug: ABT-267; Drug: pegylated interferon alpha-2a (pegIFN); Drug: Ribavirin (RBV)
Sponsors
: Abbott; Abbott
Not yet recruiting
- verified June 2012
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Combination With Ribavirin in Patients With Chronic Hepatitis C and Compensated Liver Cirrhosis (STANDART)
Tuesday, May 29, 2012, 12:00:00 PM
Condition
: Hepatitis C, Chronic
Intervention
:
Sponsors
: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting
- verified August 2012
Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)
Thursday, May 2
Post Reply
Hep C Friends
Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C
Interventions: Drug: Daclatasvir; Drug: Daclatasvir; Drug: BMS-986094; Drug: BMS-986094; Drug: BMS-986094; Drug: Ribavirin; Drug: Placebo for BMS-986094
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Suspended - verified August 2012
ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment
Interventions: Drug: RO5466731; Drug: RO5190591; Drug: ritonavir; Drug: ribavirin [Copegus]; Drug: RO5024048
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified August 2012
Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health Outcomes
Intervention: Drug: Interferon-alpha
Sponsors: University of Arizona; University of Arizona; Emory University; National Center for Complementary and Alternative Medicine (NCCAM)
Active, not recruiting - verified August 2012
Open-Label Study of GS-7977+ Ribavirin for 12 Weeks in Subjects With Chronic HCV Infection
Intervention: Drug: GS-7977 in combination with ribavirin
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified August 2012
A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon -2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous Abbott Combination Study
Interventions: Drug: ABT-450/r; Drug: ABT-267; Drug: pegylated interferon alpha-2a (pegIFN); Drug: Ribavirin (RBV)
Sponsors: Abbott; Abbott
Not yet recruiting - verified June 2012
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Combination With Ribavirin in Patients With Chronic Hepatitis C and Compensated Liver Cirrhosis (STANDART)
Intervention:
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified August 2012
Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)
Hep C Friends